ClinicalTrials.gg
TerminatedNCT07771582Updated Aug 18, 2026

Effect of Merged Exercise Versus Relaxation Techniques in Primary Dysmenorrhoea

An interventional study of Exercise and Relaxation techniques in Primary Dysmenorrhoea, sponsored by Cairo University. Terminated at 1 site in Egypt. Open to female participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-18.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Why this study was terminated
Recruitment is not achieved

From the registry’s dates

  • Registered 1 year 5 months after the study started (first participant enrolled Feb 2025, registered Jul 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 25 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 24 studies in Motor Activity by Cairo University — 5 open to participants now, 5 under way, none of them phase 3. Motor Activity · Cairo University.

Enrollment
19th of 23
40 · median 60
Started
2025
with 3 others
No phase
23 of 24
5 open now
Registered
24th of 24
by date

Among the 24 studies in Motor Activity by Cairo University, this one is the 19th largest by enrollment of the 23 interventional ones that give a count, is one of 4 that started in 2025, is one of 23 with no phase, and was the 24th registered.

Motor Activity

9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.

Browse Motor Activity studies →

Open to participants now

5 of the 24 studies in Motor Activity by Cairo University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 1,201 Motor Activity studies recruiting now, 517 (43%) set no upper age limit and 535 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 18 Years to 25 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 24 studies in Motor Activity by Cairo University, or all of them as a file.
02

Study summary

This study aims to evaluate the effect of aerobic exercises and relaxation techniques on pain severity, quality of life, and menstrual symptoms in females with primary dysmenorrhea.

Participants will be randomly assigned to either an exercise and relaxation group or a control group.

The intervention group will perform aerobic exercises and relaxation sessions for 12 weeks, while the control group will receive no intervention.

Pain levels, quality of life, and menstrual symptoms will be assessed before and after the intervention period.

03

Conditions studied

  • Primary Dysmenorrhoea

Browse trials for

Keywords

  • Exercise
  • Women
  • Primary dysmenorrhoea
  • Relaxation
04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. All females will be diagnosed as having primary dysmenorrhea
  2. All of them are virgin.
  3. They have regular menstrual cycle (a menstrual duration of 3-8 days, with 21-35 days between each two successive menstrual cycles).
  4. Their age will be ranged from 18 to 25 years old.
  5. Their (BMI) will be ranged from 18 to 25 Kg/m2.

Exclusion criteria

Exclusion Criteria:

  1. a history of pelvic inflammatory disease.
  2. myoma and tumors.
  3. pelvic infection,.
  4. ovarian cyst.
  5. any gynecological disease.
  6. any hormonal abnormality.
  7. any psychological problem.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Merged exercise

    participants will receive a structured exercises program consists of hip exercises, ,Bridging exercises ,Cobra pose ,Adductor stretching

    Behavioral: Exercise

  • Active comparator
    Relaxation techniques

    Participants will receive relaxation techniques including Meditation Yoga, Relaxation posture

    Behavioral: Relaxation techniques

Interventions

  • BehavioralExercise

    A structured exercises program consists of , Adductor stretching ,Bridging exercise, sit up exercises

  • BehavioralRelaxation techniques

    Astructured relaxation program consisting of Relaxation positure,yoga ,meditation

06

What researchers measure

Primary outcomes

  1. Serum cortisol level at week 12

    Serum cortisol levels will be measured from venous blood samples using a validated laboratory assay and reported in µg/dL (or nmol/L, depending on the laboratory). It will measured at baseline and after 12 weeks of the intervention.

    Time frame: Baseline and 8week after the intervention

  2. The Menstrual Distress Questionnaire

    The Menstrual Distress Questionnaire will be used to assess menstrual distress. It assesses 8 factors covered by 47 items. These factors include pain, concentration, behavioral change, autonomic reaction, water retention, negative effect, arousal and control.It is four point rating scale from non as no pain to severe. Maximum score is 141 meaning severe pain and minimum score is 1 meaning very mild pain

    Time frame: 12 weeks

07

Study locations

1 site
  • Faculty of physical therapy Cairo university
    Giza, Giza Government 12654, Egypt
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2025 to primary completion in May 2025, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 14, 2026
First posted
Aug 18, 2026
StartActual
Feb 12, 2025
Primary completionActual
May 12, 2025
CompletionActual
May 1, 2026
Last update
Aug 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07771582
Lead sponsor
Cairo University
Responsible party
Hoda Ali Hussein khalil (HAH student, Cairo University) — Principal investigator
First posted
Aug 18, 2026
Start date
Feb 12, 2025
Primary completion
May 12, 2025
Completion
May 1, 2026
Last update
Aug 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion